IGWM
WST icon

ICA Group Wealth Management’s West Pharmaceutical WST Stock Holding History

ICA Group Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4
Closed -$1.39K – 1415
2023
Q1 		$1.39K Hold
4
– – ﹤0.01% 1124
2022
Q4 		$941 Buy
+4
New +$948 ﹤0.01% 1181
2022
Q3 		– Sell
-824
Closed -$263K – 394
2022
Q2 		$263K Buy
824
+17
+2% +$5.53K 0.05% 308
2022
Q1 		$249K Buy
+807
New +$316K 0.05% 317

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

ICA Group Wealth Management's WST Position: Q2 2023 in Review

ICA Group Wealth Management sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 4 shares — an estimated $1.39K sold.

ICA Group Wealth Management first reported a position in WST in Q1 2022 and held it in 4 quarters. The position peaked at $263K in Q2 2022. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • ICA Group Wealth Management reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 4 West Pharmaceutical shares in Q2 2023, an estimated $1.39K.
  • ICA Group Wealth Management first reported a position in West Pharmaceutical in Q1 2022 and held it in 4 quarters.
  • ICA Group Wealth Management's West Pharmaceutical position peaked at $263K in Q2 2022.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on ICA Group Wealth Management's 13F filing for Q2 2023, filed 11 Aug 2023.